Sandberg, MK; Al-Doujaily, H; Sharps, B; De Oliveira, MW; Schmidt, C; Richard-Londt, A; Lyall, S; ... Collinge, J; + view all Sandberg, MK; Al-Doujaily, H; Sharps, B; De Oliveira, MW; Schmidt, C; Richard-Londt, A; Lyall, S; Linehan, JM; Brandner, S; Wadsworth, JD; Clarke, AR; Collinge, J; - view fewer (2014) Prion neuropathology follows the accumulation of alternate prion protein isoforms after infective titre has peaked. Nat Commun , 5 , Article 4347. 10.1038/ncomms5347.

Preview

PDF ncomms5347.pdf Download (1MB)

Abstract

Prions are lethal infectious agents thought to consist of multi-chain forms (PrP(Sc)) of misfolded cellular prion protein (PrP(C)). Prion propagation proceeds in two distinct mechanistic phases: an exponential phase 1, which rapidly reaches a fixed level of infectivity irrespective of PrP(C) expression level, and a plateau (phase 2), which continues until clinical onset with duration inversely proportional to PrP(C) expression level. We hypothesized that neurotoxicity relates to distinct neurotoxic species produced following a pathway switch when prion levels saturate. Here we show a linear increase of proteinase K-sensitive PrP isoforms distinct from classical PrP(Sc) at a rate proportional to PrP(C) concentration, commencing at the phase transition and rising until clinical onset. The unaltered level of total PrP during phase 1, when prion infectivity increases a million-fold, indicates that prions comprise a small minority of total PrP. This is consistent with PrP(C) concentration not being rate limiting to exponential prion propagation and neurotoxicity relating to critical concentrations of alternate PrP isoforms whose production is PrP(C) concentration dependent.

Download activity - last month

Export as CSVJSONXML

Download activity - last 12 months

Export as JSONCSVXML

Downloads by country - last 12 months

Export as JSONCSVXML

Archive Staff Only

View Item